PUMA BIOTECHNOLOGY, INC.: cash and cash equivalents

What this measure means

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Exact concept: us-gaap:CashAndCashEquivalentsAtCarryingValue. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2010-09-15 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• PUMA BIOTECHNOLOGY, INC.: total assets
• PUMA BIOTECHNOLOGY, INC.: total liabilities
• PUMA BIOTECHNOLOGY, INC.: stockholders equity
• PUMA BIOTECHNOLOGY, INC.: net income or loss
• PUMA BIOTECHNOLOGY, INC.: operating cash flow
• PUMA BIOTECHNOLOGY, INC.: capital expenditure payments
• PUMA BIOTECHNOLOGY, INC.: contract revenue excluding tax
• PUMA BIOTECHNOLOGY, INC.: financing cash flow
• PUMA BIOTECHNOLOGY, INC.: investing cash flow
• PUMA BIOTECHNOLOGY, INC.: retained earnings or deficit
• PUMA BIOTECHNOLOGY, INC.: basic weighted-average shares
• PUMA BIOTECHNOLOGY, INC.: diluted weighted-average shares
• PUMA BIOTECHNOLOGY, INC.: basic earnings per share
• PUMA BIOTECHNOLOGY, INC.: diluted earnings per share
• PUMA BIOTECHNOLOGY, INC.: income tax expense or benefit
• PUMA BIOTECHNOLOGY, INC.: net property, plant and equipment
• PUMA BIOTECHNOLOGY, INC.: share-based compensation expense
• PUMA BIOTECHNOLOGY, INC.: operating income or loss
• PUMA BIOTECHNOLOGY, INC.: current assets
• PUMA BIOTECHNOLOGY, INC.: interest expense
• PUMA BIOTECHNOLOGY, INC.: current liabilities
• PUMA BIOTECHNOLOGY, INC.: current accounts payable
• PUMA BIOTECHNOLOGY, INC.: net finite-lived intangible assets
• PUMA BIOTECHNOLOGY, INC.: net current accounts receivable
• PUMA BIOTECHNOLOGY, INC.: operating expenses
• PUMA BIOTECHNOLOGY, INC.: net inventory
• PUMA BIOTECHNOLOGY, INC.: selling, general and administrative expense
• PUMA BIOTECHNOLOGY, INC.: research and development expense

Inspect the source

Entity

PUMA BIOTECHNOLOGY, INC. / CIK 0001401667

Captured

2026-09-20T08:00:41.213Z

SEC response SHA-256

4b2b449f06e175eebf840b512ad515ef71296ad006f32415c1f427849828bc3d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001401667.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))